127 related articles for article (PubMed ID: 22468921)
1. Refractory anemia with ring sideroblasts associated with marked thrombocytosis harboring cytogenetic abnormality dup(2)(p15p22) treated with decitabine.
Kim J; Kim YR; Lee KA
Leuk Lymphoma; 2012 Nov; 53(11):2287-9. PubMed ID: 22468921
[No Abstract] [Full Text] [Related]
2. Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine.
Lübbert M; Wijermans P; Kunzmann R; Verhoef G; Bosly A; Ravoet C; Andre M; Ferrant A
Br J Haematol; 2001 Aug; 114(2):349-57. PubMed ID: 11529854
[TBL] [Abstract][Full Text] [Related]
3. Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T) with superimposed 5q-syndrome.
Ziarkiewicz M; Dwilewicz-Trojaczek J; Pastwińska A; Chmarzyńska E; Paszkowska-Kowalewska M; Koperski Ł; Jędrzejczak WW; Ziarkiewicz-Wróblewska B
Pol J Pathol; 2010; 61(2):105-9. PubMed ID: 20924996
[TBL] [Abstract][Full Text] [Related]
4. Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation.
Lu CM; Zhou L; Wang E; Feng S; Sebastian S; Behler C
Leuk Lymphoma; 2011 Dec; 52(12):2405-7. PubMed ID: 21806348
[No Abstract] [Full Text] [Related]
5. Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis.
Tefferi A; Al-Kali A; Begna KH; Patnaik MM; Lasho TL; Rizo A; Wan Y; Hanson CA
Blood Cancer J; 2016 Mar; 6(3):e405. PubMed ID: 26967822
[No Abstract] [Full Text] [Related]
6. High occurrence of JAK2 V617 mutation in refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Renneville A; Quesnel B; Charpentier A; Terriou L; Crinquette A; Laï JL; Cossement C; Lionne-Huyghe P; Rose C; Bauters F; Preudhomme C
Leukemia; 2006 Nov; 20(11):2067-70. PubMed ID: 16990759
[No Abstract] [Full Text] [Related]
7. Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.
Huls G; Mulder AB; Rosati S; van de Loosdrecht AA; Vellenga E; de Wolf JT
Blood; 2010 Jul; 116(2):180-2. PubMed ID: 20194893
[TBL] [Abstract][Full Text] [Related]
8. Low rate of calreticulin mutations in refractory anaemia with ring sideroblasts and marked thrombocytosis.
Broséus J; Lippert E; Harutyunyan AS; Jeromin S; Zipperer E; Florensa L; Milosevic JD; Haferlach T; Germing U; Luño E; Schnittger S; Kralovics R; Girodon F
Leukemia; 2014 Jun; 28(6):1374-6. PubMed ID: 24476766
[No Abstract] [Full Text] [Related]
9. Molecular and phenotypic heterogeneity of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
Visconte V; Tabarroki A; Hasrouni E; Maciejewski JP; Hsi ED; Tiu RV; Rogers HJ
Leuk Lymphoma; 2016; 57(1):212-5. PubMed ID: 25926061
[No Abstract] [Full Text] [Related]
10. Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis.
Flach J; Dicker F; Schnittger S; Kohlmann A; Haferlach T; Haferlach C
Haematologica; 2010 Mar; 95(3):518-9. PubMed ID: 19903679
[No Abstract] [Full Text] [Related]
11. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis.
Atallah E; Nussenzveig R; Yin CC; Bueso-Ramos C; Tam C; Manshouri T; Pierce S; Kantarjian H; Verstovsek S
Leukemia; 2008 Jun; 22(6):1295-8. PubMed ID: 18059483
[No Abstract] [Full Text] [Related]
12. Refractory anemia with ring sideroblasts and RARS with thrombocytosis.
Patnaik MM; Tefferi A
Am J Hematol; 2015 Jun; 90(6):549-59. PubMed ID: 25899435
[TBL] [Abstract][Full Text] [Related]
13. Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial.
Morita Y; Maeda Y; Yamaguchi T; Urase F; Kawata S; Hanamoto H; Tsubaki K; Ishikawa J; Shibayama H; Matsumura I; Matsuda M
Cancer Sci; 2018 Oct; 109(10):3209-3215. PubMed ID: 30007103
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
Remacha AF; Nomdedéu JF; Puget G; Estivill C; Sarda MP; Canals C; Aventin A
Haematologica; 2006 May; 91(5):719-20. PubMed ID: 16670082
[TBL] [Abstract][Full Text] [Related]
15. A brief commentary on "Refractory anemia with ring sideroblasts associated with i(17q) and mutation of the TP53 gene".
Bennett JM
Cancer Genet Cytogenet; 2003 Mar; 141(2):177. PubMed ID: 12606140
[No Abstract] [Full Text] [Related]
16. del 11(q23) as a prognostic factor of iron overload in refractory anemia with ringed sideroblasts.
Chauffaille Mde L; Stéfano JT; Valério RM; Romeo M; Rodrígues MM; Kerbauy J
Sao Paulo Med J; 1997; 115(4):1513-5. PubMed ID: 9595817
[TBL] [Abstract][Full Text] [Related]
17. Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.
Tatic A; Vasilică M; Coliţă A; Vasilache D; Dobrea C; Jardan C; Găman AM; Crişan AM; Coliţă D; Coriu D
Rom J Morphol Embryol; 2013; 54(4):1177-82. PubMed ID: 24399021
[TBL] [Abstract][Full Text] [Related]
18. Response to lenalidomide of a patient with t(2;3)(p23;q29) and JAK2 non-mutated refractory anemia with ring sideroblasts and thrombocytosis.
Zhang M; You Y; Li X; He Y; Zheng J; Li W; Zou P; Liu X; Liu F
Leuk Lymphoma; 2013 Jul; 54(7):1544-6. PubMed ID: 23252419
[No Abstract] [Full Text] [Related]
19. Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
Broseus J; Florensa L; Zipperer E; Schnittger S; Malcovati L; Richebourg S; Lippert E; Cermak J; Evans J; Mounier M; Raya JM; Bailly F; Gattermann N; Haferlach T; Garand R; Allou K; Besses C; Germing U; Haferlach C; Travaglino E; Luno E; Pinan MA; Arenillas L; Rozman M; Perez Sirvent ML; Favre B; Guy J; Alonso E; Ahwij N; Jerez A; Hermouet S; Maynadié M; Cazzola M; Girodon F
Haematologica; 2012 Jul; 97(7):1036-41. PubMed ID: 22532522
[TBL] [Abstract][Full Text] [Related]
20. Refractory anemia with ring sideroblasts associated with i(17q) and mutation of the TP53 gene.
Lazarević V; Djordjević V; Magić Z; Marisavljevic D; Colović M
Cancer Genet Cytogenet; 2002 Jul; 136(1):86-9. PubMed ID: 12165459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
